TARGRETIN 75 mg, capsule molle — flacon(s) polyéthylène haute densité (PEHD) de 100 capsule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400936574793 -
CIP7
3657479 -
CIS
69197468 -
Registration number
EU/1/01/178
What the source publishes
- Holder
- HAC PHARMA
- Active ingredients
- BEXAROTÈNE
- Form
- capsule molle
- Package
- flacon(s) polyéthylène haute densité (PEHD) de 100 capsule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2001-03-29
- Prescription
- Prescription or restricted
Names this record is found by
- TARGRETIN 75 mg, capsule molle — flacon(s) polyéthylène haute densité (PEHD) de 100 capsule(s)
- TARGRETIN 75 mg, capsule molle
- BEXAROTÈNE
Complete source data
{
"cis": "69197468",
"cip7": "3657479",
"form": "capsule molle",
"name": "TARGRETIN 75 mg, capsule molle — flacon(s) polyéthylène haute densité (PEHD) de 100 capsule(s)",
"cip13": "3400936574793",
"holder": "HAC PHARMA",
"routes": [
"orale"
],
"holders": [
"HAC PHARMA"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "461.87",
"authorisedOn": "2001-03-29",
"compositions": [
{
"name": "BEXAROTÈNE",
"nature": "SA",
"strength": "75 mg",
"linkageNumber": "1",
"substanceCode": "48410",
"dosageReference": "une capsule",
"pharmaceuticalElement": "capsule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "460.85",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "TARGRETIN 75 mg, capsule molle",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "flacon(s) polyéthylène haute densité (PEHD) de 100 capsule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2015-04-23",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"BEXAROTÈNE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/01/178",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400936574793"